Suppr超能文献

腹腔镜辅助腹主动脉瘤修复术:122例连续病例的早期和中期结果

Laparoscopy-assisted abdominal aortic aneurysm repair: early and middle-term results of a consecutive series of 122 cases.

作者信息

Ferrari Mauro, Adami Daniele, Del Corso Andrea, Berchiolli Raffaella, Pietrabissa Andrea, Romagnani Francesco, Mosca Franco

机构信息

Vascular Surgery Unit, University of Pisa, Italy.

出版信息

J Vasc Surg. 2006 Apr;43(4):695-700. doi: 10.1016/j.jvs.2005.12.056.

Abstract

BACKGROUND

Endoaneurysmorrhaphy with intraluminal graft placement, described by Creech, is the gold standard for abdominal aortic aneurysm (AAA) repair. Endovascular aneurysm repair has gained popularity for its minimal invasiveness and satisfying short-term results, but there are still many concerns about the long-term success of the procedure. Since 1998, laparoscopic surgery has been proposed for AAA treatment. The potential benefits of a minimally invasive procedure reproducing the endoaneurysmorrhaphy results over time have been advocated. In our experience, hand-assisted laparoscopic surgery (HALS) has been routinely used for the open-surgery transperitoneal/retroperitoneal approach and for endovascular aneurysm repair. After 4 years, we are able to define the early and middle-term results of such laparoscopic-assisted treatment.

METHODS

From October 2000 to March 2004, 604 consecutive nonurgent AAAs were treated at our institution. Of these, 122 (20.2%) were treated by HALS. Exclusion criteria for HALS were hostile abdomen (previous major abdominal or aortic surgery), bilateral diffuse common iliac and/or hypogastric aneurysms, massive aortoiliac calcifications, and severe cardiac (ejection fraction <35%) and respiratory (P(O2) <60 mm Hg or carbon dioxide >50 mm Hg) insufficiency. Juxtarenal and proximal iliac aneurysms were not a contraindication, nor was obesity. In all patients, we performed a minilaparotomy (7-8 cm) both for laparoscopic hand-assisted dissection and for endoaneurysmorrhaphy. All perioperative data were prospectively recorded. Follow-up consisted of ultrasonography and clinical evaluation after 6 and 12 months and then every year after surgery.

RESULTS

The mean laparoscopic and total operative times were respectively 64 +/- 32 minutes and 257 +/- 70 minutes, the mean aortic cross-clamping time was 76 +/- 26 minutes, and the mean autotransfused blood volume was 1136 +/- 711 mL. The overall mortality and morbidity were respectively 0% and 12.2%. Morbidity was surgery related in only two cases (bleeding from an ipogastric artery lesion and a leg graft thrombosis). The mean intensive care unit stay was 14.3 +/- 13 hours. Oral food intake was resumed after 27.4 +/- 15 hours, and patients were discharged after a mean of 4.4 +/- 1.7 days. Operative times were not affected by obesity, suprarenal aortic cross-clamping, or aneurysm size. Both concomitant iliac aneurysms and bifurcated graft implantation (related to longer vascular reconstruction) involved significantly longer operative times. The learning curve of the procedure (comparing the first 30 patients with the last 92 patients) led to significantly shorter endoscopic, cross-clamping, and total operative times (P = .000). The mean follow-up was 28.6 +/- 16 months. Three incisional hernias and one case of bowel occlusion were detected. All these cases (3.4%) required laparoscopic treatment.

CONCLUSIONS

The HALS technique is a safe and minimally invasive treatment for AAA; it is useful for limiting the need for conventional open surgery and reducing the length of hospital stay. Despite the lack of randomized studies, HALS seems to be associated with a better postoperative course than standard open surgery. HALS can also be considered as an equivalent of a well-established procedure and as a bridge between open and total laparoscopic surgery.

摘要

背景

克里奇描述的腔内移植物置入的动脉瘤内缝合法是腹主动脉瘤(AAA)修复的金标准。血管内动脉瘤修复术因其微创性和令人满意的短期效果而受到欢迎,但对于该手术的长期成功仍存在许多担忧。自1998年以来,已有人提出用腹腔镜手术治疗AAA。有人主张随着时间推移,一种微创方法再现动脉瘤内缝合法结果具有潜在益处。根据我们的经验,手辅助腹腔镜手术(HALS)已常规用于开放手术经腹/腹膜后入路以及血管内动脉瘤修复。4年后,我们能够确定这种腹腔镜辅助治疗的早期和中期结果。

方法

从2000年10月至2004年3月,我们机构连续治疗了604例非急诊AAA患者。其中,122例(20.2%)接受了HALS治疗。HALS的排除标准为腹部情况不佳(既往有重大腹部或主动脉手术史)、双侧弥漫性髂总动脉和/或下腹动脉瘤、大量主髂动脉钙化以及严重心脏(射血分数<35%)和呼吸(P(O2)<60 mmHg或二氧化碳>50 mmHg)功能不全。肾旁和近端髂动脉瘤不是禁忌证,肥胖也不是。在所有患者中,我们均进行了小切口剖腹术(7 - 8 cm),用于腹腔镜手辅助解剖和动脉瘤内缝合法。所有围手术期数据均进行前瞻性记录。随访包括术后6个月和12个月时的超声检查和临床评估,之后每年进行一次。

结果

腹腔镜平均手术时间和总手术时间分别为64±32分钟和257±70分钟,主动脉平均阻断时间为76±26分钟,平均自体输血血量为1136±711 mL。总体死亡率和发病率分别为0%和12.2%。发病率仅在两例中与手术相关(下腹动脉病变出血和腿部移植物血栓形成)。重症监护病房平均住院时间为14.3±13小时。术后27.4±15小时恢复经口进食,患者平均在4.4±1.7天后出院。手术时间不受肥胖、肾动脉上方主动脉阻断或动脉瘤大小的影响。同时存在的髂动脉瘤和分叉移植物植入(与更长的血管重建相关)均导致手术时间显著延长。该手术的学习曲线(比较前30例患者与后92例患者)使内镜、阻断和总手术时间显著缩短(P = 0.000)。平均随访时间为28.6±16个月。检测到3例切口疝和1例肠梗阻。所有这些病例(3.4%)均需腹腔镜治疗。

结论

HALS技术是一种安全且微创的AAA治疗方法;它有助于减少传统开放手术的需求并缩短住院时间。尽管缺乏随机研究,但HALS似乎比标准开放手术具有更好的术后过程。HALS也可被视为一种成熟手术的等效方法以及开放手术和全腹腔镜手术之间的桥梁。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验